Search Breaking New Ground Our Science Our Therapy Areas About Us AstraZeneca to present anifrolumab lupus data at Annual European Congress of Rheumatology (EULAR 2016) PUBLISHED 8 June 2016 Share New analyses of Phase II trial demonstrate improvement of symptoms in multiple organ domains including skin and joints 8 June 2016 Important notice for users You are about to access MedImmune historic archive material. Any reference in these archives to MedImmune products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. Please refer to your approved national product label (SmPC) for current product information. I have read this warning and will not be using any of the contained product information for clinical purposes. I disagree I agree ?